Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract, and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.
This month, we are featuring how to navigate the rapidly changing landscape of dry eye care. We now have multiple medications targeting different types of dry eye. In an ideal world, it would be great to be able to get a specific medication targeting a specific type of dry eye in the hands of a patient. Unfortunately, due to insurance coverage, we are often unable to control which medication a patient receives. Kourtney H. Houser, MD, and Nandini Venkateswaran, MD, discuss how they handle this issue.
Kenneth A. Beckman, MD, FACS
OSN CEDARS/ASPENS Debates Editor
Point person is key to prescriptions
When it comes to dry eye care, a lot of times we do not have a choice. There is what we wish we could do and what we have to do.
Our dry eye treatment armamentarium has expanded. We now have many options for prescription treatment including steroid-sparing anti-inflammatories with various agents, concentrations and vehicles; low-concentration steroids; antiparasitics; and tear film stabilizers.
Source: Healio